Marketing-authorisation holder · United States
Quagen
9 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE325mg; 50mg; 40mg | 500mg; 50mg; 40mg | 750mg; 50mg; 40mg · Tablet | Paracetamol, Butalbital, Caffeine | United States | Marketed | 1984 |
| CLONAZEPAM0.5mg | 1mg | 2mg · Tablet | Clonazepam | United States | Marketed | 1996 |
| DEMEROL100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Pethidine | United States | Not marketed | 1942 |
| DEMEROL50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Syrup | Pethidine | United States | Not marketed | 1942 |
| ELDEPRYL5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Selegiline | United States | Not marketed | 1996 |
| METHYLPHENIDATE HYDROCHLORIDE10mg | 2.5mg | 5mg · Tablet, chewable | Methylphenidate | United States | Marketed | 2015 |
| RITONAVIR100mg · Capsule | Ritonavir | United States | Marketed | 2020 |
| UREX1GM · Tablet | Methenamine | United States | Marketed | 1967 |
| URSODIOL150mg | 200mg | 300mg | 400mg · Capsule | Ursodeoxycholic acid | United States | Marketed | 2000 |